Sepsis, low platelet nadir at mobilization and previous IFN use predict stem cell mobilization failure in patients with multiple myeloma

By Putkonen M.   Rauhala A.   Pelliniemi T-T   Remes K.  

Cytotherapy, Vol. 9, Iss. 6, 2007-01 ,pp. : 548-554

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Characterization of hematopoietic stem cell subsets from patients with multiple myeloma after mobilization with plerixafor

By Taubert Isabel   Saffrich Rainer   Zepeda-Moreno Abraham   Hellwig Isabelle   Eckstein Volker   Bruckner Thomas   Ho Anthony D.   Wuchter Patrick  

Cytotherapy, Vol. 13, Iss. 4, 2011-04 ,pp. : 459-466

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Lymphocyte subset analysis for the assessment of treatment-related complications after autologous stem cell transplantation in multiple myeloma

By Lee Sung-Eun   Yahng Seung-Ah   Cho Byung-Sik   Eom Ki-Seong   Kim Yoo-Jin   Kim Hee-Je   Lee Seok   Cho Seok-Goo   Kim Dong-Wook   Lee Jong-Wook   Min Woo-Sung   Park Chong-Won   Min Chang-Ki  

Cytotherapy, Vol. 14, Iss. 4, 2012-04 ,pp. : 505-512

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Effects of peripheral blood stem cell apheresis on systemic cytokine levels in patients with multiple myeloma

By Akkök Çiğğdem Akalin   Hervig Tor   Stamnesfet Siren   Nesthus Ingerid   Melve Guro K.   Lassalle Philippe   Bruserud Øystein  

Cytotherapy, Vol. 13, Iss. 10, 2011-11 ,pp. : 1259-1268

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Predictors of high yield and purify of CD34⁺ cell-selected PBPC, collected from patients with multipe myeloma

By Webb I J   Scholssman R L   Jiroutek M   Doss D   Cohen C A   Freeman A   Schott D M   Anderson K C  

Cytotherapy, Vol. 1, Iss. 3, 1999-01 ,pp. : 175-182

Ashgate Publishing Ltd

Access to resources Recommend Favorite